Blinatumomab for CNI-Resistant/Intolerant SRNS in Children

Clinical trial NCT06607991 · RECRUITING

Trial details

NCT number: NCT06607991
Sponsor: The Children's Hospital of Zhejiang University School of Medicine
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

CNI-resistant Steriod Resistant Nephrotic Syndrome CNI-intolerent Steriod Resistant Nephrotic Syndrome Multidrug Resistant Nephrotic Syndrome

Start date: 2024-09-19
Primary completion: 2026-09-19
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.